March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Merck & Co... We recently published a list of the 11 Best Pharma Stocks to Buy According ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The samples were fixed in 2% glutaraldehyde solution in cacodylate buffer (Merck, Darmstadt, Germany) for two hours, dehydrated in increasing concentrations of ethanol (30%, 50%, 75%, 80%, 90%, 95% ...

After hours: March 13 at 7:59:21 PM EDT ...

As of 12:42:05 pm GMT-4. Market open. Loading Chart for MRK ...